| Bioactivity | Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potently, and reversibly to the active site of FXIa and thereby inhibits its activity. Asundexian inhibits human FXIa in buffer with an IC50 of 1 nM[1]. | |||||||||
| In Vivo | Asundexian displays potent anticoagulant activity in vitro in human and rabbit plasma and antithrombotic efficacy in vivo in a rabbit arterial thrombosis model[1]. | |||||||||
| Name | Asundexian | |||||||||
| CAS | 2064121-65-7 | |||||||||
| Formula | C26H21ClF4N6O4 | |||||||||
| Molar Mass | 592.93 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Thomas D, et al. First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa. J Thromb Haemost. 2021;19(10):2407-2416. |
Asundexian
CAS: 2064121-65-7 F: C26H21ClF4N6O4 W: 592.93
Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potentl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.